Conference call regarding Elekta’s Interim Report for May-January 2015/16

To take part in the conference call, please dial in about five minutes in advance.

• UK dial-in number: +44 (0) 203 008 8 11
• US dial-in number: +1 855 753 22 36
• Swedish dial-in number: +46 (0)8 566 426 64

The telephone conference will also be broadcasted live online through the following link (however, please call in also in order to ask questions): http://event.onlineseminarsolutions.com/r.htm?e=1130188&s=1&k=D687F74BEEB287B382610C038CAC32A2

# # #

For further information, please contact:
Johan Andersson, Director Investor Relations, Elekta AB.
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

Frida Johansson, Investor Relations, Elekta AB
Tel: +46 708 667 674, e- mail: frida.johansson@elekta.com
Time zone: CET: Central European Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.